Dose escalation study of ARN-509 with everolimus in patients with progressive metastatic castration-resistant prostate cancer.
Latest Information Update: 23 Jul 2014
At a glance
- Drugs Apalutamide (Primary) ; Everolimus
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 23 Jul 2014 New trial record